Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum RenovoRx Inc RNXT

Healthcare Drug Manufacturers - Specialty & Generic
RenovoRx, Inc. is a clinical and a commercial biopharmaceutical company. Its lead product RenovoCath a local drug delivery device, targeting high unmet medical needs. RenovoRx’s patented Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to ensure targeted therapeutic delivery across the arterial wall near the tumor site to bathe the target tumor. RenovoRx’s novel approach to... see more

Bullboard (NDAQ:RNXT)

View:
1 2 3 Next
User Avatar Image
(10)
•••
  • Mathew177X
Post by Mathew177on Oct 25, 2024 1:40pm

An Undervalued Biotech Showing Promise

An Undervalued Biotech Showing Promise https://10xalerts.com/an-undervalued-biotech-showing-promise/
62
User Avatar Image
(10)
•••
  • MikeTesterX
Post by MikeTesteron Aug 01, 2024 7:12pm

RenovoRx, Inc. (RNXT): Pioneering Precision Oncology with Pr

https://beyondspx.com/2024/08/01/renovorx-inc-rnxt-pioneering-precision-oncology-with-promising-clinical-results/
38
User Avatar Image
(6)
•••
  • ElliotGHX
Post by ElliotGHon Jul 16, 2024 11:36am

RenovoRx’s Breakthroughs in Targeted Cancer Treatments

RenovoRx’s Breakthroughs in Targeted Cancer Treatments (NASDAQ: RNXT) https://10xalerts.com/renovorxs-breakthroughs-in-targeted-cancer-treatments/
46
User Avatar Image
(10)
•••
  • Mathew177X
Post by Mathew177on Jul 09, 2024 9:35am

RenovoRx Announces Acceptance for Publication

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist® (NASDAQ: RNXT) https://www.stocktitan.net/news/RNXT ...more  
57
User Avatar Image
(10)
•••
  • Mathew177X
Post by Mathew177on Jun 26, 2024 9:38am

University of Nebraska Medical Center Launches Patient

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRxs Pivotal Phase III TIGeR-PaC Clinical Trial (NASDAQ: RNXT) https://finance.yahoo.com/news/university-nebraska-medical ...more  
56
User Avatar Image
(6)
•••
  • ElliotGHX
Post by ElliotGHon Jun 17, 2024 9:16am

Ascendiant Capital highlights cancer therapy, sees potential

Ascendiant Capital highlights cancer therapy, sees potential on RenovoRx stock (NASDAQ: RNXT) https://in.investing.com/news/company-news/ascendiant-capital ...more  
66
User Avatar Image
(10)
•••
  • Mathew177X
Post by Mathew177on May 30, 2024 9:44am

RenovoRx CEO Issues Update Letter to Shareholders

RenovoRx CEO Issues Update Letter to Shareholders (NASDAQ: RNXT) https://www.businesswire.com/news/home/20240529881953/en/RenovoRx-CEO-Issues-Update-Letter-to ...more  
70
User Avatar Image
(10)
•••
  • Mathew177X
Post by Mathew177on May 29, 2024 11:53am

Exploring RenovoRx’s Breakthroughs in Targeted Cancer Treat

Exploring RenovoRx’s Breakthroughs in Targeted Cancer Treatments (NASDAQ: RNXT) https://10xalerts.com/exploring-renovorxs-breakthroughs-in-targeted-cancer ...more  
88
User Avatar Image
(9)
•••
  • averagepenniesX
Post by averagepennieson Dec 21, 2023 10:04am

RenovoRx Engages Oklahoma University (OU) Health as First

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a ...more  
100
User Avatar Image
(9)
•••
  • averagepenniesX
Post by averagepennieson Dec 19, 2023 9:37am

RenovoRx Announces Clinical Data Abstract at the 2024 Societ

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform ...more  
124
User Avatar Image
(9)
•••
  • averagepenniesX
Post by averagepennieson Dec 13, 2023 10:32am

RenovoRx Files New International Patent for Novel Targeted C

RenovoRx Holds a Strong Intellectual Property (IP) Portfolio with 9 Issued Patents for its Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Therapy Platform and Delivery System New Patent Would ...more  
99
User Avatar Image
(38)
•••
  • BryceCanadaX
Post by BryceCanadaon Nov 29, 2023 8:45am

New video out from RNXT CEO!

https://youtu.be/Y5QcOFlvHk8?si=mmZC-JFov9HQla8X
93
User Avatar Image
(38)
•••
  • BryceCanadaX
Post by BryceCanadaon Nov 20, 2023 9:11am

New one out from RNTX!

https://youtu.be/4Q6MWrPl66g?si=ZxR7SIXt8KiCHSwf
81
User Avatar Image
(38)
•••
  • BryceCanadaX
Post by BryceCanadaon Mar 29, 2023 5:03pm

Excellent YT analysis on RNXT!

https://youtu.be/Cz4OeKoaE-4
74
User Avatar Image
(107)
•••
  • IseneschalX
Post by Iseneschalon Nov 10, 2021 3:06pm

RNXT ..... stopped out

That's it for me
84
1 2 3 Next
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities